144 related articles for article (PubMed ID: 33309014)
1. Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications.
Pang TCY; Po JW; Becker TM; Goldstein D; Pirola RC; Wilson JS; Apte MV
Pancreatology; 2021 Jan; 21(1):103-114. PubMed ID: 33309014
[TBL] [Abstract][Full Text] [Related]
2. Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer.
Bissolati M; Sandri MT; Burtulo G; Zorzino L; Balzano G; Braga M
Tumour Biol; 2015 Feb; 36(2):991-6. PubMed ID: 25318603
[TBL] [Abstract][Full Text] [Related]
3. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.
Catenacci DV; Chapman CG; Xu P; Koons A; Konda VJ; Siddiqui UD; Waxman I
Gastroenterology; 2015 Dec; 149(7):1794-1803.e4. PubMed ID: 26341722
[TBL] [Abstract][Full Text] [Related]
5. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
6. Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancreatic cancer.
Cheng H; He W; Yang J; Ye Q; Cheng L; Pan Y; Mao L; Chu X; Lu C; Li G; Qiu Y; He J
Cell Prolif; 2020 Sep; 53(9):e12880. PubMed ID: 32707596
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer.
Reddy RM; Murlidhar V; Zhao L; Grabauskiene S; Zhang Z; Ramnath N; Lin J; Chang AC; Carrott P; Lynch W; Orringer MB; Beer DG; Nagrath S
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):852-858. PubMed ID: 26614417
[TBL] [Abstract][Full Text] [Related]
8. Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer.
Hashimoto M; Tanaka F; Yoneda K; Takuwa T; Matsumoto S; Okumura Y; Kondo N; Tsubota N; Tsujimura T; Tabata C; Nakano T; Hasegawa S
Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):775-83. PubMed ID: 24618055
[TBL] [Abstract][Full Text] [Related]
9. Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result.
Kurihara T; Itoi T; Sofuni A; Itokawa F; Tsuchiya T; Tsuji S; Ishii K; Ikeuchi N; Tsuchida A; Kasuya K; Kawai T; Sakai Y; Moriyasu F
J Hepatobiliary Pancreat Surg; 2008; 15(2):189-95. PubMed ID: 18392713
[TBL] [Abstract][Full Text] [Related]
10. Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
Huebner H; Fasching PA; Gumbrecht W; Jud S; Rauh C; Matzas M; Paulicka P; Friedrich K; Lux MP; Volz B; Gass P; Häberle L; Meier-Stiegen F; Hartkopf A; Neubauer H; Almstedt K; Beckmann MW; Fehm TN; Ruebner M
BMC Cancer; 2018 Feb; 18(1):204. PubMed ID: 29463222
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.
Ankeny JS; Court CM; Hou S; Li Q; Song M; Wu D; Chen JF; Lee T; Lin M; Sho S; Rochefort MM; Girgis MD; Yao J; Wainberg ZA; Muthusamy VR; Watson RR; Donahue TR; Hines OJ; Reber HA; Graeber TG; Tseng HR; Tomlinson JS
Br J Cancer; 2016 Jun; 114(12):1367-75. PubMed ID: 27300108
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications.
Tjensvoll K; Nordgård O; Smaaland R
Int J Cancer; 2014 Jan; 134(1):1-8. PubMed ID: 23447365
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation.
Bobek V; Gurlich R; Eliasova P; Kolostova K
World J Gastroenterol; 2014 Dec; 20(45):17163-70. PubMed ID: 25493031
[TBL] [Abstract][Full Text] [Related]
14. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
Court CM; Ankeny JS; Sho S; Winograd P; Hou S; Song M; Wainberg ZA; Girgis MD; Graeber TG; Agopian VG; Tseng HR; Tomlinson JS
Ann Surg Oncol; 2018 Apr; 25(4):1000-1008. PubMed ID: 29442211
[TBL] [Abstract][Full Text] [Related]
15. Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer.
Ning D; Cui K; Liu M; Ou Y; Wang Z; Zou B; Shen Y; Lu X; Li S; Li P
Med Sci Monit; 2021 Jan; 27():e926565. PubMed ID: 33408319
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic ultrasound acquired portal venous circulating tumor cells predict progression free survival and overall survival in patients with pancreaticobiliary cancers.
Chapman CG; Ayoub F; Swei E; Llano EM; Li B; Siddiqui UD; Waxman I
Pancreatology; 2020 Dec; 20(8):1747-1754. PubMed ID: 33082106
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
18. A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver Metastases.
Tien YW; Kuo HC; Ho BI; Chang MC; Chang YT; Cheng MF; Chen HL; Liang TY; Wang CF; Huang CY; Shew JY; Chang YC; Lee EY; Lee WH
Medicine (Baltimore); 2016 Apr; 95(16):e3407. PubMed ID: 27100430
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of circulating tumor cells and therapy response in pancreatic cancer.
Okubo K; Uenosono Y; Arigami T; Mataki Y; Matsushita D; Yanagita S; Kurahara H; Sakoda M; Kijima Y; Maemura K; Natsugoe S
Eur J Surg Oncol; 2017 Jun; 43(6):1050-1055. PubMed ID: 28233633
[TBL] [Abstract][Full Text] [Related]
20. Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival.
Tamminga M; Andree KC; van den Bos H; Hiltermann TJN; Mentink A; Spierings DCJ; Lansdorp P; Timens W; Schuuring E; Terstappen LWMM; Groen HJM
Br J Cancer; 2022 Feb; 126(3):409-418. PubMed ID: 34848855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
